Can We See with Melanopsin?


Journal

Annual review of vision science
ISSN: 2374-4650
Titre abrégé: Annu Rev Vis Sci
Pays: United States
ID NLM: 101660822

Informations de publication

Date de publication:
15 09 2020
Historique:
pubmed: 4 6 2020
medline: 28 7 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

A small fraction of mammalian retinal ganglion cells are directly photoreceptive thanks to their expression of the photopigment melanopsin. These intrinsically photosensitive retinal ganglion cells (ipRGCs) have well-established roles in a variety of reflex responses to changes in ambient light intensity, including circadian photoentrainment. In this article, we review the growing evidence, obtained primarily from laboratory mice and humans, that the ability to sense light via melanopsin is also an important component of perceptual and form vision. Melanopsin photoreception has low temporal resolution, making it fundamentally biased toward detecting changes in ambient light and coarse patterns rather than fine details. Nevertheless, melanopsin can indirectly impact high-acuity vision by driving aspects of light adaptation ranging from pupil constriction to changes in visual circuit performance. Melanopsin also contributes directly to perceptions of brightness, and recent data suggest that this influences the appearance not only of overall scene brightness, but also of low-frequency patterns.

Identifiants

pubmed: 32491960
doi: 10.1146/annurev-vision-030320-041239
doi:

Substances chimiques

Rod Opsins 0
melanopsin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-468

Auteurs

Robert J Lucas (RJ)

Centre for Biological Timing and Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom; email: Robert.Lucas@manchester.ac.uk.

Annette E Allen (AE)

Centre for Biological Timing and Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom; email: Robert.Lucas@manchester.ac.uk.

Nina Milosavljevic (N)

Centre for Biological Timing and Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom; email: Robert.Lucas@manchester.ac.uk.

Riccardo Storchi (R)

Centre for Biological Timing and Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom; email: Robert.Lucas@manchester.ac.uk.

Tom Woelders (T)

Centre for Biological Timing and Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom; email: Robert.Lucas@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH